Ex-FDA scientist criticizes White House's booster announcement as premature and 'not helpful'
The FDA's independent panel of vaccine advisers will meet Friday to consider the ongoing booster shot discussion, as well vote on whether to advise approving boosters for people 16 and older, The New York Times reports. Recently, scientists, administration officials, and public health agencies have been at odds over who needs booster shots and when, despite a White House roll out beginning Sept. 20. The CDC will discuss the matter next week.
Ahead of the meetings, however, former FDA Chief Scientist Dr. Jesse Goodman shared his thoughts on the matter with CNN's New Day, noting that while he believes Biden's chief medical adviser Dr. Anthony Fauci — who has backed the fall booster rollout, given fears of waning vaccine immunity — to have "tremendous expertise," the White House's premature decision was "not helpful."
Article continues belowThe Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I think any number of decisions could be reasonable here," Goodman added, seeming to allude to the outcome of the agencies' meetings, "and it's just going to be really important to explain the evidence and the decisions to the American people."
Watch more below:
